Egalet Corporation is a fully integrated specialty pharmaceutical company developing and commercializing medicines for acute and chronic pain, with a particular focus on oral products designed to deter prescription-drug abuse. Its Guardian Technology uses physical and chemical barriers alongside tailored drug release, while the company’s manufacturing approach combines pharmaceutical production with plastic injection molding. Egalet has marketed OXAYDO and SPRIX and has described late-stage abuse-deterrent opioid candidates in its pipeline.